The use of
immunomodulatory agents for the treatment of
cancer is gaining a growing
biopharmaceutical interest. Antibody-
cytokine fusion
proteins, namely immunocytokines, represent a promising
solution for the regulation of the immune system at the site of disease. The three-dimensional arrangement of these molecules can profoundly influence their
biological activity and pharmacokinetic properties. Structural techniques might provide important insight in the 3D arrangement of immunocytokines. Here, we performed structure investigations on clinical grade fusion
proteins L19-IL2, IL12-L19L19 and L19L19-IL2 to elucidate their quaternary organization. Crystallographic characterization of the common L19
antibody fragment at a resolution of 2.0-Å was combined with low-resolution studies of the full-length chimeric molecules using small-angle
synchrotron X-ray scattering (SAXS) and negative
stain electron microscopy. Characterization of the full-length quaternary structures of the immunocytokines in
solution by SAXS consistently supported the diabody structure in the
L19-IL2 immunocytokine and allowed generation of low-resolution models of the chimeric
proteins L19L19-IL2 and IL12-L19L19. Comparison with 3D reconstructions obtained from negative-
stain electron microscopy revealed marked flexibility associated to the linker regions connecting the
cytokine and the antibody components of the chimeric
proteins. Collectively, our results indicate that low-resolution molecular structure characterizations provide useful complementary insights for the quality control of immunocytokines, constituting a powerful tool to guide the design and the subsequent optimization steps towards clinical enhancement of these chimeric
protein reagents.